Scientists Look to Treat Tumors with the Help of Man’s Best Friend
The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases.
Monrovia, CA, November 04, 2006 --(PR.com)-- Pet dogs naturally develop the some of same types of cancers that occur in humans, such as non-Hodgkin lymphoma and osteosarcoma. The Comparative Oncology Program (COP) at the National Cancer Institute launched a new program in February 2006 designed to make dog trials work much like drug studies done in humans. Melissa C. Paoloni of the COP says that canine models are important because they “capture the true essence of the disease.”
Paoloni will be among the scientists presenting at an upcoming conference on Model Organisms in Drug Discovery. The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases.
Model Organisms in Drug Discovery is a part of the 2nd Modern Drug Discovery & Development Summit (M3D 2006). The Summit will take place December 4-6, 2006 at the Pennsylvania Convention Center. Over 250 speakers will participate in 11 concurrent conferences. For more information, visit www.gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
For more information contact Christy Bowman at GTCbio. Phone: (626) 256-6405 x101, Fax: (626) 256-6460, Email: Christy.bowman@gtcbio.com
###
Paoloni will be among the scientists presenting at an upcoming conference on Model Organisms in Drug Discovery. The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases.
Model Organisms in Drug Discovery is a part of the 2nd Modern Drug Discovery & Development Summit (M3D 2006). The Summit will take place December 4-6, 2006 at the Pennsylvania Convention Center. Over 250 speakers will participate in 11 concurrent conferences. For more information, visit www.gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
For more information contact Christy Bowman at GTCbio. Phone: (626) 256-6405 x101, Fax: (626) 256-6460, Email: Christy.bowman@gtcbio.com
###
Contact
GTCbio
Christy Bowman
626-256-6405
www.gtcbio.com
Christy Bowman
626-256-6405
www.gtcbio.com
Contact
Categories